Evidence map›Paper›PMID 38193690›Full record

ArticleJournal of virology2024

Individual herpes simplex virus 1 (HSV-1) particles exit by exocytosis and accumulate at preferential egress sites.

Melissa H Bergeman, Michaella Q Hernandez, Jenna Diefenderfer, Jake A Drewes, Kimberly Velarde, Wesley M Tierney, Junior A Enow, Honor L Glenn, Masmudur M Rahman, Ian B Hogue

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Melissa H BergemanASU-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, Arizona, USA.
Michaella Q HernandezASU-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, Arizona, USA.
Jenna DiefenderferSchool of Life Sciences, Arizona State University, Tempe, Arizona, USA.
Jake A DrewesSchool of Life Sciences, Arizona State University, Tempe, Arizona, USA.
Kimberly VelardeSchool of Life Sciences, Arizona State University, Tempe, Arizona, USA.
Wesley M TierneyASU-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, Arizona, USA.
Junior A EnowSchool of Life Sciences, Arizona State University, Tempe, Arizona, USA.
Honor L GlennSchool of Life Sciences, Arizona State University, Tempe, Arizona, USA.
Masmudur M RahmanSchool of Life Sciences, Arizona State University, Tempe, Arizona, USA.
Ian B HogueASU-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0002-1977-5573
Arizona State University · US

Funding

Studies in Poxvirus Host Range Genes and TropismR01AI080607 · NIAID · UNIVERSITY OF FLORIDA · PI RAHMAN, MASMUDUR MOHAMMED · 2009 to 2025
$5.6M
Molecular and cellular mechanisms of HSV-1 assembly and egressR01NS117513 · NINDS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI Ian B Hogue · 2022 to 2026
$2.0M
Molecular and Cellular Mechanisms of Herpes Simplex Transport and Egress Pathway in NeuronsK22AI123159 · NIAID · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI HOGUE, IAN B · 2017 to 2018
$261k
NIAID NIH HHS K22 AI123159NIAID NIH HHS R01 AI080607NINDS NIH HHS R01 NS117513
6 · The paper itself

Abstract

The human pathogen herpes simplex virus 1 (HSV-1) produces a lifelong infection in the majority of the world's population. While the generalities of alpha herpesvirus assembly and egress pathways are known, the precise molecular and spatiotemporal details remain unclear. In order to study this aspect of HSV-1 infection, we engineered a recombinant HSV-1 strain expressing a pH-sensitive reporter, gM-pHluorin. Using a variety of fluorescent microscopy modalities, we can detect individual virus particles undergoing intracellular transport and exocytosis at the plasma membrane. We show that particles exit from epithelial cells individually, not bulk release of many particles at once, as has been reported for other viruses. In multiple cell types, HSV-1 particles accumulate over time at the cell periphery and cell-cell contacts. We show that this accumulation effect is the result of individual particles undergoing exocytosis at preferential sites and that these egress sites can contribute to cell-cell spread. We also show that the viral membrane proteins gE, gI, and US9, which have important functions in intracellular transport in neurons, are not required for preferential egress and clustering in non-neuronal cells. Importantly, by comparing HSV-1 to a related alpha herpesvirus, pseudorabies virus, we show that this preferential exocytosis and clustering effect are cell type dependent, not virus dependent. This preferential egress and clustering appear to be the result of the arrangement of the microtubule cytoskeleton, as virus particles co-accumulate at the same cell protrusions as an exogenous plus end-directed kinesin motor.IMPORTANCEAlpha herpesviruses produce lifelong infections in their human and animal hosts. The majority of people in the world are infected with herpes simplex virus 1 (HSV-1), which typically causes recurrent oral or genital lesions. However, HSV-1 can also spread to the central nervous system, causing severe encephalitis, and might also contribute to the development of neurodegenerative diseases. Many of the steps of how these viruses infect and replicate inside host cells are known in depth, but the final step, exiting from the infected cell, is not fully understood. In this study, we engineered a novel variant of HSV-1 that allows us to visualize how individual virus particles exit from infected cells. With this imaging assay, we investigated preferential egress site formation in certain cell types and their contribution to the cell-cell spread of HSV-1.

Indexed as

ExocytosisHerpes SimplexHerpesvirus 1, HumanVirus ReleaseAnimalsBiological TransportHumansNeuronsegressexocytosisfluorescent image analysisherpes simplex virussecretory pathway

Identifiers

PMID38193690
PMCPMC10883806
OpenAlexW4390769329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.